Previously treated cases tested for RR-/MDR-TB (%) in Uruguay
Uruguay: Previously treated cases tested for RR-/MDR-TB was 95.0% in 2024. ▲ Rising
Previously treated cases tested for RR-/MDR-TB in Uruguay, 2006–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Uruguay recorded 95.0% for previously treated cases tested for rr-/mdr-tb in 2024. That is the highest value across all 18 years on record.
That represents a change of up 30.1% on the previous year and up 143.6% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Uruguay peaked at 95.0% in 2020 and was at its lowest, 39.0%, in 2014.
That places Uruguay 66th out of 180 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Previously treated cases tested for RR-/MDR-TB in Uruguay, year by year
| Year | Value | Change |
|---|---|---|
| 2006 | 66.0% | — |
| 2007 | 70.0% | +6.1% |
| 2008 | 77.0% | +10.0% |
| 2010 | 54.0% | -29.9% |
| 2011 | 72.0% | +33.3% |
| 2012 | 76.0% | +5.6% |
| 2013 | 57.0% | -25.0% |
| 2014 | 39.0% | -31.6% |
| 2015 | 69.0% | +76.9% |
| 2016 | 77.0% | +11.6% |
| 2017 | 56.0% | -27.3% |
| 2018 | 84.0% | +50.0% |
| 2019 | 71.0% | -15.5% |
| 2020 | 95.0% | +33.8% |
| 2021 | 63.0% | -33.7% |
| 2022 | 60.0% | -4.8% |
| 2023 | 73.0% | +21.7% |
| 2024 | 95.0% | +30.1% |
Uruguay compared with similar countries
- Uruguay's 95.0% is above the median for high income countries, which is 83.0%, 1.1× the median. (57 countries reporting)
- Uruguay's 95.0% is above the median for Latin America & Caribbean, which is 85.0%, 1.1× the median. (29 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 71.0% | 66.0% | 77.0% | 3 |
| 2010s | 65.5% | 39.0% | 84.0% | 10 |
| 2020s | 77.2% | 60.0% | 95.0% | 5 |
Countries ranked near Uruguay
More health data for Uruguay
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6727 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,631 deaths per 1,000 people (2090)
- Number of infants who die before age 1 31 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.79 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0241 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.84 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Uruguay?
- Previously treated cases tested for rr-/mdr-tb in Uruguay was 95.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Uruguay?
- The highest recorded value was 95.0% in 2020.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Uruguay?
- The lowest recorded value was 39.0% in 2014.
- How does Uruguay rank for previously treated cases tested for rr-/mdr-tb?
- Uruguay ranks 66th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Uruguay?
- Over the last ten years it is up 143.6%. The long-run trend across the full record is rising.
- Where does this Uruguay data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).